
1. j virol methods. 2010 aug;167(2):205-7. doi: 10.1016/j.jviromet.2010.03.017. epub
2010 mar 31.

a multicenter evaluation abbott realtime hcv genotype ii assay.

ciotti m(1), marcuccilli f, guenci t, babakir-mina m, chiodo f, favarato m, perno
cf.

author information: 
(1)laboratory molecular virology, foundation university hospital tor vergata, 
viale oxford, 81-00133, rome, italy. marco.ciotti@ptvonline.it

genotype determination recommended starting anti-hcv therapy to
determine duration treatment (peg-interferon+ribavirin). versant hcv
genotype 2.0 assay, based reverse hybridization 5'utr segment and
core region hepatitis c virus (hcv), one assays used most
widely hcv genotyping. multicenter evaluation automated abbott 
realtime hcv genotype ii assay carried 124 hcv positive sera tested
previously versant hcv genotype 2.0 assay. good agreement
between two assays. type concordance 95.9% (117/122) concordance at
the subtype level genotype 1 95.6% (43/45). abbott realtime hcv
genotype ii assay automated, allowing substantial reduction time-to
results hands-on time. combined features full automation, objective
interpretation digital archiving make assay useful diagnostic
setting.

copyright (c) 2010 elsevier b.v. rights reserved.

doi: 10.1016/j.jviromet.2010.03.017 
pmid: 20362009  [indexed medline]

